Spire Healthcare Group PLC Holding(s) in Company (2033T)
10 October 2017 - 9:12PM
UK Regulatory
TIDMSPI TIDM42SB
RNS Number : 2033T
Spire Healthcare Group PLC
10 October 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
---------------------------------------------------------------------------------------------------------------------------
1a. Identity of the issuer Spire Healthcare Group plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
-------------------------------------------------- -----------------------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
---------------------------------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- ------------------------------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
---------------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------- ------------------------------------
An acquisition or disposal of financial instruments X
------------------------------------------------------------------------------------- ------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- ------------------------------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- ------------------------------------
3. Details of person subject to the notification obligation(iv)
Name The Goldman Sachs Group,
Inc.
City and country of registered Corporation Trust Center,
office (if applicable) 1209 Orange Street, Wilmington
DE 19801, USA
4. Full name of shareholder(s) (if different from 3.)(v)
---------------------------------------------------------------------------------------------------------------------------
Name
-------------------------------------------------- -----------------------------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------------- -----------------------------------------------------------------------
5. Date on which the threshold 05/10/2017
was crossed or reached(vi)
:
-------------------------------------------------- -----------------------------------------------------------------------
6. Date on which issuer notified 09/10/2017
(DD/MM/YYYY):
-------------------------------------------------- -----------------------------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
---------------------------------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
---------------------------- -------------------- ---------------- --------------- ------------------------------------
Resulting
situation
on the date
on which threshold
was crossed
or reached 1.76% 0.44% 2.21% 401,081,391
---------------------------- -------------------- ---------------- --------------- ------------------------------------
Position of
previous notification
(if
applicable) 1.76% 1.31% 3.08%
---------------------------- -------------------- ---------------- --------------- ------------------------------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------
Class/type Number of voting % of voting rights
of rights(ix)
shares
ISIN code (if
possible)
-----------------
Direct Indirect Direct Indirect
(Art 9 (Art 10 of (Art 9 of (Art 10 of
of Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------- --------------- -------------- ---------------------------------- --------------
GB00BNLPYF73 7,068,178 1.76%
----------------- --------------- -------------- ---------------------------------- --------------
SUBTOTAL 8.
A 7,068,178 1.76%
----------------- ------------------------------- --------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date(x) Conversion rights that rights
instrument Period(xi) may be acquired
if the instrument
is
exercised/converted.
----------------- --------------- -------------- ---------------------------------- --------------
Securities
Lending Open 1,782,953 0.44%
----------------- --------------- -------------- ---------------------------------- --------------
SUBTOTAL 8.
B 1 1,782,953 0.44%
-------------- ---------------------------------- --------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
---------------- ---------------- -------------- ---------------- ---------------- --------------
SUBTOTAL
8.B.2
---------------- ---------------- --------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
-------------------------------------------------------------------------------------- --------------
Name(xv) % of voting % of voting Total of both
rights if rights through if it equals
it equals financial or is higher
or is higher instruments than the notifiable
than the notifiable if it equals threshold
threshold or is higher
than the
notifiable
threshold
----------------- ------------------------------- ---------------- --------------------------------
The Goldman
Sachs
Group, Inc.
----------------- ------------------------------- ---------------- --------------------------------
Goldman Sachs
(UK) L.L.C.
----------------- ------------------------------- ---------------- --------------------------------
Goldman Sachs
Group UK
Limited
----------------- ------------------------------- ---------------- --------------------------------
Goldman Sachs
International
----------------- ------------------------------- ---------------- --------------------------------
The Goldman
Sachs
Group, Inc.
----------------- ------------------------------- ---------------- --------------------------------
GSAM Holdings
LLC
----------------- ------------------------------- ---------------- --------------------------------
Goldman Sachs
Asset
Management,
L.P.
----------------- ------------------------------- ---------------- --------------------------------
The Goldman
Sachs
Group, Inc.
----------------- ------------------------------- ---------------- --------------------------------
GSAM Holdings
LLC
----------------- ------------------------------- ---------------- --------------------------------
GS Investment
Strategies, LLC
----------------- ------------------------------- ---------------- --------------------------------
10. In case of proxy voting, please identify:
------------------------------------------------------------------------------------------------------
Name of the proxy holder N/A
-------------------------------------------------- --------------------------------------------------
The number and % of voting N/A
rights held
-------------------------------------------------- --------------------------------------------------
The date until which the N/A
voting rights will be held
-------------------------------------------------- --------------------------------------------------
11. Additional information(xvi)
------------------------------------------------------------------------------------------------------
Please note, total amount of voting rights have been
rounded to 2 decimal places therefore there is a possibility
of a rounding error.
General email contact:
shareholderdisclosures@gs.com
------------------------------------------------------------------------------------------------------
Place of completion London
-------------------- -----------
Date of completion 09/10/2017
-------------------- -----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLURARRBRARAAA
(END) Dow Jones Newswires
October 10, 2017 06:12 ET (10:12 GMT)
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Apr 2024 to May 2024
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From May 2023 to May 2024